Should Canada develop a list of essential medicines?
Tuesday, May 23rd, 2017
|Tuesday, May 23, 2017||3:00PM - 5:00PM||108N, North House, 1 Devonshire Place|
The World Health Organization recommends that each state define its own list of essential medicines. Essential medicines lists generally contain hundreds of medicines including treatments for acute conditions (e.g. pneumonia, anaphylaxis, sprained ankles) and chronic diseases (e.g. diabetes, HIV-AIDS, hypertension). Lists of essential medicines can help governments ensure adequate healthcare services are delivered by identifying the medications that are needed by people.
More than 100 countries have developed essential medicine lists. Canada is not one of them.
Should Canada develop a list of essential medicines? We will learn from two international experts about the benefits and challenges of creating an essential medicines list: Dr Nicola Magrini from the World Health Organization’s Essential medicines group and Professor Lars Gustaffson from the Swedish “Wise List”. Then we will hear the reactions of Canadian decision makers before we open up the discussion to involve all participants.
This event is supported by the WHO Collaborating Center for Governance, Accountability and Transparency for the Pharmaceutical Sector.
Please note that events posted on this website are considered to be public events – unless otherwise stated – and you are choosing to enter a space where your image and/or voice may be captured as part of event proceedings that may be made public as part of a broadcast, webcast, or publication (online and in print). We make every effort to ensure your personal information is kept and used in compliance with the Freedom of Information and Protection of Privacy Act (FIPPA). If you have any questions please get in touch with our office at firstname.lastname@example.org or 416-946-8900.